GeekWire
APRIL 11, 2023
Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. He was first hired by Adaptive as chief technology officer. She previously held commercial development roles at Pfizer. Mark Adams.
GeekWire
NOVEMBER 28, 2023
MagniX’s chief technology officer, Riona Armesmith, works on electric propulsion systems like the one in the background at the company’s headquarters in Everett, Wash. where scores of employees design, develop and manufacture electric powertrains. Read the other profiles here. I like electronics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeekWire
OCTOBER 20, 2020
Thielke is currently managing director of Hines Asia Pacific, a global real estate investment, development and management firms. The founding team includes: • CEO Peter Horadan, previously EVP of engineering and CTO at tax automation startup Avalara. Goldsmith was most recently CTO at identity verification provider Onfido.
GeekWire
DECEMBER 13, 2022
Protheroe previously worked at the UK-based Royal College of Art as director of development and alumni relations. Yang is a biotech vet who worked at Adaptive Biotechnologies, AstraZeneca, and Genentech before joining the Allen Institute, a Seattle-based nonprofit founded almost 20 years ago by Paul Allen, the late Microsoft co-founder. .
GeekWire
JUNE 14, 2023
It acquired Adaptive Technology Group in 2019. Adaptive Biotechnologies Corporation disclosed in a SEC filing that Leslie Trigg is voluntarily resigning from the company’s board. based startup Smarsh named Vinay Mehta as its new CTO. He previously worked as CTO and information officer at customer loyalty company cxLoyalty.
GeekWire
JANUARY 10, 2022
Adaptive Biotechnologies Photo). Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. Principal accounting officer Kyle Piskel will serve as interim CFO after Cohen resigns. Sirosh is currently CTO of real estate platform company Compass. Chad Cohen. Vancouver, Wash.-based
GeekWire
NOVEMBER 19, 2020
Umoja Biopharma raised $53 million to expand development of its CAR T-cell immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. Ryan Crisman , a veteran of ZymoGenetics, Juno Therapeutics, and Gates Biomanufacturing Facility who is Umoja’s CTO. Umoja Biopharma CEO Andy Scharenberg.
Expert insights. Personalized for you.
105 
Let's personalize your content